[Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000517:prevention & control; D002994:Clofibrate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged
D008055:Lipids; D002994:Clofibrate
Zmeny spektra lipidov krvného séra po trojmesacnom podávani Clofibratu Spofa.